RARE

Ultragenyx Pharm

• NASDAQ·13h ago

  Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Lags Revenue Estimates

• Simply Wall St·1d ago

  A Look At Ultragenyx Pharmaceutical (RARE) Valuation After FDA Acceptance Of UX111 Resubmitted BLA

• PR Newswire·2d ago

  RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm

• PR Newswire·2d ago

  Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE

• PR Newswire·4d ago

  RARE Deadline: RARE Investors with Losses in Excess of $100K Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit

• PR Newswire·5d ago

  DEADLINE NEXT WEEK: Berger Montague Advises Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) Investors to Contact the Firm Before April 6, 2026

• Simply Wall St·5d ago

  Why Ultragenyx Pharmaceutical (RARE) Is Up 12.2% After FDA Accepts UX111 Gene Therapy BLA Review

• TipRanks·5d ago

  Ultragenyx Insider Move: CFO’s Stock Sale Sparks Fresh Investor Buzz

• Reuters·6d ago

  BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford

• Reuters·6d ago

  BUZZ-Ultragenyx rises after FDA accepts marketing application for rare disease therapy

• TipRanks·6d ago

  Ultragenyx BLA for UX111 Accepted for FDA Review

• Seeking Alpha·6d ago

  Ultragenyx says gene therapy accepted for FDA review again

• NASDAQ·6d ago

  Ultragenyx BLA For UX111 Gene Therapy Accepted By FDA

• TipRanks·6d ago

  Ultragenyx UX111 AAV9 biologics license application accepted for FDA review

• Reuters·6d ago

  FDA accepts Ultragenyx resubmitted UX111 BLA for Sanfilippo syndrome A therapy